Organization: Health Canada
Year: 2024
Month: September
Request Number: A-2024-000647
Request Summary: With respect to generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient mesalazine, if the applicant has made a request for reconsideration of Health Canada’s decision, a copy of the applicant’s Letter of Intent, Health Canada’s Eligibility Letter, applicant’s Request for Reconsideration, Health Canada’s Invitation Letter, copy of any recommendation from the Internal Review or External Reconsideration Panel, and any reconsideration decision letter.
Disposition: No records exist
Number of pages: 0